{
"raw_text": "{\n  \"base_id\": \"base_anticoagulation_0190\",\n  \"evaluation\": {\n    \"summary\": \"The patient is a female aged 75-84 with atrial fibrillation, hypertension, and GERD on anticoagulation therapy with warfarin 5mg daily and aspirin 81mg daily. Vitals and labs are within acceptable ranges with an INR of 2.2, which is within the therapeutic range for atrial fibrillation. Blood pressure and heart rate are stable. Kidney function is preserved with an eGFR of 85 mL/min/1.73m\u00b2 and serum creatinine of 1.0 mg/dL.\",\n    \"medication_review\": {\n      \"warfarin\": {\n        \"indication_appropriate\": true,\n        \"dose_appropriate\": true,\n        \"INR_target\": \"2.0-3.0\",\n        \"current_inr\": 2.2,\n        \"comments\": \"INR within therapeutic range for atrial fibrillation.\"\n      },\n      \"aspirin\": {\n        \"indication\": \"May increase bleeding risk in combination with warfarin.\",\n        \"suggestion\": \"Assess risk versus benefit for concomitant aspirin use; if no recent ischemic event or stenting, consider discontinuation to reduce bleeding risk.\"\n      }\n    },\n    \"risk_assessment\": {\n      \"bleeding_risk\": \"Increased due to dual antithrombotic therapy (warfarin + aspirin).\",\n      \"recommendation\": \"Evaluate need for aspirin; monitor for potential bleeding complications given age and combined therapy.\"\n    },\n    \"recommendations\": [\n      \"Continue warfarin with regular INR monitoring to maintain therapeutic range.\",\n      \"Reassess the indication for aspirin therapy to minimize bleeding risk, especially if primary prevention only.\",\n      \"Maintain monitoring of blood pressure and kidney function.\",\n      \"Educate patient on signs of bleeding and importance of medication adherence.\"\n    ],\n    \"disclaimers\": \"FOR EVALUATION ONLY - NOT CLINICAL USE.\"\n  }\n}",
"model_id": "openai",
"version": "gpt-4.1-mini",
"prompt_tokens": 352,
"completion_tokens": 424,
"latency_seconds": 5.1433259999903385
}